Sigma Planning Corp Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Sigma Planning Corp

$3.16 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$144.95 - $152.29 $40,441 - $42,488	279 Added 11.15%	2,781 $420,000
Q2 2022 Aug 11, 2022	SELL	$83.14 - $145.99 $331,229 - $581,624	-3,984 Reduced 61.42%	2,502 $365,000
Q1 2022 Apr 20, 2022	BUY	$110.08 - $142.92 $42,490 - $55,167	386 Added 6.33%	6,486 $769,000
Q4 2021 Feb 02, 2022	SELL	$99.73 - $148.48 $26,727 - $39,792	-268 Reduced 4.21%	6,100 $841,000
Q3 2021 Oct 28, 2021	SELL	$98.85 - $138.91 $92,919 - $130,575	-940 Reduced 12.86%	6,368 $885,000
Q2 2021 Aug 13, 2021	SELL	$65.78 - $105.02 $80,843 - $129,069	-1,229 Reduced 14.4%	7,308 $709,000
Q1 2021 May 06, 2021	BUY	$64.07 - $91.75 $52,985 - $75,877	827 Added 10.73%	8,537 $584,000
Q4 2020 Feb 09, 2021	SELL	$65.07 - $98.24 $384,758 - $580,893	-5,913 Reduced 43.4%	7,710 $661,000
Q3 2020 Nov 03, 2020	SELL	$59.04 - $77.95 $42,508 - $56,124	-720 Reduced 5.02%	13,623 $886,000
Q2 2020 Jul 31, 2020	SELL	$29.01 - $74.23 $101,912 - $260,769	-3,513 Reduced 19.67%	14,343 $1.05 Million
Q1 2020 May 01, 2020	BUY	$27.51 - $57.29 $27,179 - $56,602	988 Added 5.86%	17,856 $608,000
Q4 2019 Feb 03, 2020	SELL	$40.86 - $57.65 $85,806 - $121,065	-2,100 Reduced 11.07%	16,868 $918,000
Q3 2019 Nov 01, 2019	SELL	$37.38 - $49.47 $33,642 - $44,523	-900 Reduced 4.53%	18,968 $791,000
Q2 2019 Aug 01, 2019	BUY	$39.79 - $67.01 $204,998 - $345,235	5,152 Added 35.01%	19,868 $870,000
Q1 2019 May 01, 2019	SELL	$34.52 - $53.29 $6,627 - $10,231	-192 Reduced 1.29%	14,716 $757,000
Q4 2018 Jan 31, 2019	BUY	$29.75 - $42.9 $53,758 - $77,520	1,807 Added 13.79%	14,908 $551,000
Q3 2018 Nov 07, 2018	SELL	$32.79 - $43.0 $11,804 - $15,480	-360 Reduced 2.67%	13,101 $492,000
Q2 2018 Aug 02, 2018	SELL	$23.62 - $42.29 $86,921 - $155,627	-3,680 Reduced 21.47%	13,461 $532,000
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $30,091 - $46,241	1,338 Added 8.47%	17,141 $442,000
Q4 2017 Feb 07, 2018	BUY	$20.44 - $35.56 $16,352 - $28,448	800 Added 5.33%	15,803 $426,000
Q3 2017 Nov 06, 2017	BUY	$23.54 - $38.21 $353,170 - $573,264	15,003	15,003 $561,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account